By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Medicines Agency (EMA) 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a



Company News
Shire (SHPG) Announces EMA Validation Of Veyvondi [Von Willebrand Factor (Recombinant)] Marketing Authorization Application For Treatment Of Von Willebrand Disease 6/22/2017 10:02:57 AM
Novartis AG (NVS) Achieves Important Regulatory Milestone For AMG 334 (Erenumab) In Migraine Prevention With EMA Filing Acceptance 6/21/2017 8:15:21 AM
Innocrin Granted SME Status Designation By EMA 6/20/2017 10:13:40 AM
Therachon Receives EMA And FDA Orphan Drug Designation For TA-46 For Achondroplasia 6/20/2017 6:05:54 AM
Tarix Orphan Granted Orphan Drug Status By The EMA For TXA127 As Potential Treatment For Epidermolysis Bullosa (EB) 6/12/2017 6:50:33 AM
Mithra Pharmaceuticals Receives Orphan Drug Designation From EMA For E4 In Neonatal Encephalopathy 6/9/2017 9:12:22 AM
Edge Therapeutics Receives Pediatric Investigation Plan Waiver From The EMA 6/8/2017 11:04:18 AM
Sangamo (SGMO) And Pfizer (PFE) Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The EMA 6/7/2017 7:26:12 AM
EMA Accepts Design Of NeuroDerm (NDRM)'s ND0612 Phase III Indigo Efficacy Trial 6/6/2017 7:24:17 AM
Sandoz Proposed Biosimilars Adalimumab And Infliximab Accepted For Regulatory Review By The EMA 5/31/2017 10:56:32 AM